Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1986-03-10
1988-11-08
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 21, 514822, A61K 31725, C08B 3710
Patent
active
047834471
ABSTRACT:
A process for producing natural heparan sulphate and dermatan sulphate for mixtures of proteoglycans from the aorta, myocardium and particularly vascularized organs, based on a series of precipitation and purification steps which enable the protein part of the proteoglycan to be eliminated and the two products to be obtained in substantially pure form, without any chemical or enzymatic degradation.
When administered orally or parenterally, the heparan sulphate obtained exerts activation effects on antithrombin III and on the fibrinolytic process.
The dermatan sulphate obtained exerts an inhibiting effect on Factor Xa and also possesses the property of activating the fibrinolytic effect of heparan sulphate.
REFERENCES:
patent: 3862003 (1975-01-01), Okuyama et al.
patent: 4243582 (1981-01-01), Spilburg et al.
De Ambrosi Luigi
Del Bono Rinaldo
Ferrari Gianni
Pagella Piergiuseppe
Mediolanum Farmaceutici Srl
Rollins John W.
LandOfFree
Process for producing natural heparan sulphate and dermatan sulp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing natural heparan sulphate and dermatan sulp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing natural heparan sulphate and dermatan sulp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-464116